Scarica l'app Stockscreener
28.63
4.37%
1.20
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ALKS Giù?
Forum
Previsione
Frazionamento azionario
Alkermes Plc Borsa (ALKS) Ultime notizie
Live Scanner Shows Breakout on Alkermes plcMarket Surge Signal for Swing Traders Triggered - metal.it
Is Alkermes plc in a long term uptrendWealth Leverage Stock List - mustnews.co.kr
BlackRock increases stake in Alkermes to 17% - Investing.com India
BlackRock increases stake in Alkermes to 17% By Investing.com - Investing.com Nigeria
Alkermes plc Included in Top Momentum ScanInvestment Strategy Designed for Capital Protection - metal.it
Chondrosarcoma Market: Epidemiology, Pipeline Products, - openPR.com
Alkermes plc Announces Pricing of New Term Loans - AOL.com
What markets is AAON Inc. expanding into Is Alkermes plc stock a good long term investment optionBuild a diversified portfolio for steady growth - Jammu Links News
What is the dividend policy of Alkermes plc stockUnmatched market gains - Jammu Links News
Is Alkermes plc a growth stock or a value stockInvest smarter with expert trading signals - Jammu Links News
What makes Alkermes plc stock price move sharplyInvest confidently with professional advice - Jammu Links News
Is Alkermes plc stock overvalued or undervaluedGet exclusive access to expert stock recommendations - Jammu Links News
Alkermes Q2 Earnings Beat Estimates, Proprietary Drugs Aid Sales - MSN
What catalysts could drive Alkermes plc stock higher in 2025Invest confidently with professional advice - Jammu Links News
Should I hold or sell Alkermes plc stock in 2025Get expert analysis on top stock picks - Jammu Links News
Needham & Company LLC Reaffirms "Buy" Rating for Alkermes (NASDAQ:ALKS) - MarketBeat
How does Alkermes plc generate profit in a changing economyBuild capital through low-risk investments - Jammu Links News
What are analysts’ price targets for Alkermes plc in the next 12 monthsAchieve rapid portfolio growth with expert guidance - Jammu Links News
What are the technical indicators suggesting about Alkermes plcDiscover investment plans that deliver results - Jammu Links News
How strong is Alkermes plc company’s balance sheetUnlock powerful portfolio optimization tools - Jammu Links News
What markets is Alkermes plc expanding into Is ASLE stock a good long term investment optionBuild a portfolio that outperforms consistently - Jammu Links News
Alkermes Reports Q2 2025 Financial Results, Reiterates Expectations and Highlights Positive Clinical Study Results - AInvest
ALKERMES INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Alkermes plc To Contact The Firm - ACCESS Newswire
Alkermes shares climb 5% following Q2 earnings and revenue beat - MSN
(07/31/25) ALKS: Positive Narcolepsy Drug Trial Puts this Biotech Name in F - moneyshow.com
Alkermes anticipates record proprietary product sales above $1B for 2025 as orexin pipeline advances - MSN
Alkermes: A More Than Solid Quarter (NASDAQ:ALKS) - Seeking Alpha
Alkermes stock price target raised to $42 from $40 at RBC Capital - Investing.com Nigeria
Alkermes plc (NASDAQ:ALKS) Q2 2025 Earnings Call Transcript - Insider Monkey
Alkermes Beat Expectations With A Strong Second Quarter - Finimize
Schizophrenia Drugs Market Exclusive Report with Detailed - openPR.com
RBC Raises Price Target on Alkermes to $42 From $40, Keeps Sector Perform Rating - MarketScreener
Alkermes PLC (ALKS) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
Alkermes: Q2 Earnings Snapshot - Norwalk Hour
Alkermes Reports Strong Q2 2025 Financial Results - TipRanks
Trading Bots Trigger Alerts on Alkermes plc ActivityDaily Smart Money Movement Monitor Activated - metal.it
Multi Factor Analysis Ranks Alkermes plc as Strong BuyAI Driven Stock Trend Forecast Shows Momentum Shift - metal.it
Alkermes Earnings Call: Strong Growth and Promising Trials - TipRanks
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Alkermes plc of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 22, 2018ALKS - ACCESS Newswire
Alkermes price target lowered to $33 from $35 at BofA - TipRanks
Why Alkermes plc stock attracts strong analyst attentionScalable Portfolio Growth Suggestions Released - metal.it
Alkermes Q2 2025 Earnings Call Transcript - MarketBeat
Published on: 2025-07-29 17:34:19 - metal.it
Alkermes (ALKS) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance
2.18%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):